<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardiovascular</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиоваскулярная терапия и профилактика</journal-title><trans-title-group xml:lang="en"><trans-title>Cardiovascular Therapy and Prevention</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1728-8800</issn><issn pub-type="epub">2619-0125</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1728-8800-2025-4575</article-id><article-id custom-type="edn" pub-id-type="custom">ZUKTPU</article-id><article-id custom-type="elpub" pub-id-type="custom">cardiovascular-4575</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПЕРЕДОВАЯ СТАТЬЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>EDITORIAL</subject></subj-group></article-categories><title-group><article-title>Стандартизация биобанкирования в России: оценка уровня внедрения, проблемы и перспективы</article-title><trans-title-group xml:lang="en"><trans-title>Biobanking standardization in Russia: assessment of the implementation, challenges and prospects</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4020-6647</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Борисова</surname><given-names>А. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Borisova</surname><given-names>A. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Анна Львовна Борисова — н.с., руководитель лаборатории "Банк биологического материала" Института персонализированной терапии и профилактики.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">a.borisova0108@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5989-6233</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мешков</surname><given-names>А. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Meshkov</surname><given-names>A. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Алексей Николаевич Мешков — д.м.н., руководитель Института персонализированной терапии и профилактики.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">meshkov@lipidclinic.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6985-7131</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Покровская</surname><given-names>М. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Pokrovskaya</surname><given-names>M. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мария Сергеевна Покровская — к.б.н., в.н.с. лаборатории "Банк биологического материала" Института персонализированной терапии и профилактики.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">mpokrovskaia@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8665-9129</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Метельская</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Metelskaya</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Виктория Алексеевна Метельская — д.б.н., профессор, г.н.с. лаборатории изучения биохимических маркеров риска хронических неинфекционных заболеваний им. Н. В. Перовой отдела фундаментальных и прикладных аспектов ожирения.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990; ул. Баррикадная, д. 2/1, стр. 1, Москва, 125993</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990; Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">VMetelskaya@gnicpm.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4453-8430</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Драпкина</surname><given-names>О. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Drapkina</surname><given-names>O. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Оксана Михайловна Драпкина — д.м.н., профессор, директор.</p><p>Петроверигский пер., 10, стр. 3, Москва, 101990</p></bio><bio xml:lang="en"><p>Petroverigsky Lane, 10, bld. 3, Moscow, 101990</p></bio><email xlink:type="simple">drapkina@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ "Национальный медицинский исследовательский центр терапии и профилактической медицины" Минздрава России; ФГБОУ ДПО "Российская медицинская академия непрерывного профессионального образования" Минздрава России</institution></aff><aff xml:lang="en"><institution>National Medical Research Center for Therapy and Preventive Medicine; Russian Medical Academy of Continuous Professional Education</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>23</day><month>01</month><year>2026</year></pub-date><volume>24</volume><issue>11</issue><fpage>4575</fpage><lpage>4575</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Борисова А.Л., Мешков А.Н., Покровская М.С., Метельская В.А., Драпкина О.М., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Борисова А.Л., Мешков А.Н., Покровская М.С., Метельская В.А., Драпкина О.М.</copyright-holder><copyright-holder xml:lang="en">Borisova A.L., Meshkov A.N., Pokrovskaya M.S., Metelskaya V.A., Drapkina O.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://cardiovascular.elpub.ru/jour/article/view/4575">https://cardiovascular.elpub.ru/jour/article/view/4575</self-uri><abstract><sec><title>Цель</title><p>Цель. Проведение оценки степени внедрения международных стандартов биобанкирования в деятельность российских биобанков — членов НАСБИО (Национальной ассоциации биобанков и специалистов по биобанкированию), а также готовности и заинтересованности специалистов в сертификации и аккредитации российских биобанков.</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Для оценки уровня стандартизации деятельности российских биобанков в июне 2025г была разработана анкета, включающая четыре блока вопросов, посвященных стандартизации процесса биобанкирования, внедрению систем менедж­мента качества и перспективам сертификации. Анкетирование проводилось с июля по август 2025г среди представителей российских биобанков — членов НАСБИО. Для анализа результатов анкетирования применялись методы описательной статистики.</p></sec><sec><title>Результаты</title><p>Результаты. В анкетировании приняли участие представители 20 организаций. Все участники опроса письменно подтвердили свое согласие на обработку персональных данных. Большинство участников опроса представляло биобанки, созданные на базе государственных научно-­медицинских учреждений. Результаты опроса показали, что в российских биобанках применяются и активно внедряются обязательные процедуры управления качеством. При этом лишь четыре биобанка сертифицированы по стандарту Международной организации по стандартизации (ISO — International organization of standardization) 9001. Отмечена высокая заинтересованность специалистов в получении сертификатов соответствия ISO 20387.</p></sec><sec><title>Заключение</title><p>Заключение. Результаты опроса показали, что российские специалисты в области биобанкирования в целом демонстрируют приверженность качеству и заинтересованность в стандартизации деятельности биобанков. Отсутствие в России четкого юридического поля в отношении исследовательских биобанков образцов человека и аккредитованных органов по проведению сертификации биобанков по стандарту ISO 20387 остаются ограничивающими факторами для обмена коллекциями и их совместного использования в научных исследованиях и разработках.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To assess the implementation of international standards in Russian biobanking — members of National Association of Biobanks and Biobanking Specialists (NASBIO), as well as the willingness and interest of specialists in certification and accreditation of Russian biobanks.</p></sec><sec><title>Material and methods</title><p>Material and methods. To assess the level of standardization of Rus­sian biobanks in June 2025, a questionnaire was developed con­sisting of four sets of questions on biobanking standardization, the im­plementation of quality management systems, and the prospects for certification. A survey was conducted from July to August 2025 among representatives of Russian biobanks — NASBIO members. Descriptive statistics were used to analyze the survey results.</p></sec><sec><title>Results</title><p>Results. Representatives of 20 organizations participated in the survey. All participants provided written consent to personal data processing. The majority of survey participants represented biobanks established at state research and medical institutions. The survey results showed that Russian biobanks apply and actively implement mandatory quality management procedures. However, only four biobanks are certified according to the International Organization for Standardization (ISO) 9001 standard. High interest among specialists in obtaining ISO 20387 certificates of conformity was noted.</p></sec><sec><title>Conclusion</title><p>Conclusion. The survey results showed that Russian biobanking spe­cialists generally demonstrate a commitment to quality and an interest in standardizing biobank operations. The lack of a clear legal framework in Russia for research biobanks of human samples and accredited bo­dies for biobank certification according to ISO 20387 remain limiting fac­tors for the exchange of collections and their shared use in research and development.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>биобанк</kwd><kwd>биобанкирование</kwd><kwd>система менедж­мента качества</kwd><kwd>стандартизация</kwd><kwd>качество</kwd></kwd-group><kwd-group xml:lang="en"><kwd>biobank</kwd><kwd>biobanking</kwd><kwd>quality management system</kwd><kwd>stan­dar­dization</kwd><kwd>quality</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Государственное задание "Свободно циркулирующие микроРНК плазмы крови как диагностические и прогностические биомаркеры ИБС"</funding-statement><funding-statement xml:lang="en">Relationships and Activities. State assignment "Circulating Micro­RNAs in Plasma as Diagnostic and Prognostic Biomarkers of CAD"</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Simeon-­Dubach D, Watson P. Biobanking 3.0: evidence based and customer focused biobanking. Clin Biochem. 2014;47(4-5):300-8. doi:10.1016/j.clinbiochem.2013.12.018.</mixed-citation><mixed-citation xml:lang="en">Simeon-­Dubach D, Watson P. Biobanking 3.0: evidence based and customer focused biobanking. Clin Biochem. 2014;47(4-5):300-8. doi:10.1016/j.clinbiochem.2013.12.018.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Furuta K, Allocca CM, Schacter B, et al. Standardization and In­novation in Paving a Path to a Better Future: An Update of Ac­tivities in ISO/TC276/WG2 Biobanks and Bioresources. Bio­preserv Biobank. 2018;16(1):23-7. doi:10.1089/bio.2017.0117.</mixed-citation><mixed-citation xml:lang="en">Furuta K, Allocca CM, Schacter B, et al. Standardization and In­novation in Paving a Path to a Better Future: An Update of Ac­tivities in ISO/TC276/WG2 Biobanks and Bioresources. Bio­preserv Biobank. 2018;16(1):23-7. doi:10.1089/bio.2017.0117.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Müller H, Dagher G, Loibner M, et al. Biobanks for life sciences and personalized medicine: importance of standardization, bio­safety, biosecurity, and data management. Curr Opin Biotechnol. 2020;65:45-51. doi:10.1016/j.copbio.2019.12.004.</mixed-citation><mixed-citation xml:lang="en">Müller H, Dagher G, Loibner M, et al. Biobanks for life sciences and personalized medicine: importance of standardization, bio­safety, biosecurity, and data management. Curr Opin Biotechnol. 2020;65:45-51. doi:10.1016/j.copbio.2019.12.004.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Борисова А. Л., Покровская М. С., Мешков А. Н. и др. Стан­дарт по биобанкированию ISO 20387. Анализ требований и опыт внедрения. Клиническая лабораторная диагностика. 2020; 65(9):587-92. doi:10.18821/0869-2084-2020-65-9-587-592.</mixed-citation><mixed-citation xml:lang="en">Borisova AL, Pokrovskaya MS, Meshkov AN, et al. ISO 20387 bio­banking standard. Analysis of requirements and experience of im­ple­mentation. Klinicheskaya Laboratornaya Diagnostika [Russian Clinical Laboratory Diagnostics]. 2020;65(9):587-92. (In Russ.) doi:10.18821/0869-2084-2020-65-9-587-592.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Dagher G. Quality matters: International standards for biobanking. Cell Prolif. 2022;55(8):e13282. doi:10.1111/cpr.13282.</mixed-citation><mixed-citation xml:lang="en">Dagher G. Quality matters: International standards for biobanking. Cell Prolif. 2022;55(8):e13282. doi:10.1111/cpr.13282.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Anisimov SV, Meshkov AN, Glotov AS, et al. National Association of Biobanks and Biobanking Specialists: New Community for Promoting Biobanking Ideas and Projects in Russia. Biopreserv Biobank. 2021;19(1):73-82. doi:10.1089/bio.2020.0049.</mixed-citation><mixed-citation xml:lang="en">Anisimov SV, Meshkov AN, Glotov AS, et al. National Association of Biobanks and Biobanking Specialists: New Community for Promoting Biobanking Ideas and Projects in Russia. Biopreserv Biobank. 2021;19(1):73-82. doi:10.1089/bio.2020.0049.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Moore HM, Kelly A, Jewell SD, et al. Biospecimen Reporting for Improved Study Quality. Biopreserv Biobank. 2011;9(1):57-70. doi:10.1089/bio.2010.0036.</mixed-citation><mixed-citation xml:lang="en">Moore HM, Kelly A, Jewell SD, et al. Biospecimen Reporting for Improved Study Quality. Biopreserv Biobank. 2011;9(1):57-70. doi:10.1089/bio.2010.0036.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Сивакова О. В., По­кров­ская М. С., Метельская В. А. и др. Международные правила описания биообразцов — важный фактор повышения качества научных исследований. Профилактическая медицина. 2019;22(6):95-9. doi:10.17116/profmed20192206295.</mixed-citation><mixed-citation xml:lang="en">Sivakova OV, Pokrovskaya MS, Metelskaya VA, et al. International rules for description of biospecimens are an important factor in improving the quality of researches. Russian Journal of Pre­ven­tive Medicine. 2019;22(6):95-9. (In Russ.) doi:10.17116/profmed20192206295.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Lehmann S, Guadagni F, Moore H, et al. Standard preanalytical co­ding for biospecimens: review and implementation of the Sam­ple PREanalytical Code (SPREC). Biopreserv Biobank. 2012; 10(4):366-74. doi:10.1089/bio.2012.0012.</mixed-citation><mixed-citation xml:lang="en">Lehmann S, Guadagni F, Moore H, et al. Standard preanalytical co­ding for biospecimens: review and implementation of the Sam­ple PREanalytical Code (SPREC). Biopreserv Biobank. 2012; 10(4):366-74. doi:10.1089/bio.2012.0012.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Betsou F, Bilbao R, Case J, et al. Standard PREanalytical Code Version 3.0. Biopreserv Biobank. 2018;16(1):9-12. doi:10.1089/bio.2017.0109.</mixed-citation><mixed-citation xml:lang="en">Betsou F, Bilbao R, Case J, et al. Standard PREanalytical Code Version 3.0. Biopreserv Biobank. 2018;16(1):9-12. doi:10.1089/bio.2017.0109.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Henderson MK, Simeon-­Dubach D, Zaayenga A. When bad things happen: lessons learned from effective and not so effective disaster and recovery planning for biobanks. Biopreserv Biobank. 2013;11(4):193. doi:10.1089/bio.2013.1141.</mixed-citation><mixed-citation xml:lang="en">Henderson MK, Simeon-­Dubach D, Zaayenga A. When bad things happen: lessons learned from effective and not so effective disaster and recovery planning for biobanks. Biopreserv Biobank. 2013;11(4):193. doi:10.1089/bio.2013.1141.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Akyüz K, Chassang G, Goisauf M, et al. Biobanking and risk as­ses­sment: a comprehensive typology of risks for an adaptive risk go­vernance. Life Sci Soc Policy. 2021;17(1):10. doi:10.1186/s40504-021-00117-7.</mixed-citation><mixed-citation xml:lang="en">Akyüz K, Chassang G, Goisauf M, et al. Biobanking and risk as­ses­sment: a comprehensive typology of risks for an adaptive risk go­vernance. Life Sci Soc Policy. 2021;17(1):10. doi:10.1186/s40504-021-00117-7.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Parry-­Jones A, Allocca CM. Best Practices Make Perfect. Bio­preserv Biobank. 2023;21(6):533-4. doi:10.1089/bio.2023.29128.editorial.</mixed-citation><mixed-citation xml:lang="en">Parry-­Jones A, Allocca CM. Best Practices Make Perfect. Bio­preserv Biobank. 2023;21(6):533-4. doi:10.1089/bio.2023.29128.editorial.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Sargsyan K, Jaksa B, Hartl G, Macheiner T. Risk Management in Biobanks. In: Risk Management and Assessment. Eds. Rocha J, Oliveira S, Capinha C. London, IntechOpen. 2020;1-32. ISBN: 978-1-83880-795-5. doi:10.5772/intechopen.91463.</mixed-citation><mixed-citation xml:lang="en">Sargsyan K, Jaksa B, Hartl G, Macheiner T. Risk Management in Biobanks. In: Risk Management and Assessment. Eds. Rocha J, Oliveira S, Capinha C. London, IntechOpen. 2020;1-32. ISBN: 978-1-83880-795-5. doi:10.5772/intechopen.91463.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Борисова А. Л., Покровская М. С., Мешков А. Н. и др. Управление рисками в биобанкировании. Кардиоваскулярная терапия и профилактика. 2022;21(11): 3400. doi:10.15829/1728-8800-2022-3400.</mixed-citation><mixed-citation xml:lang="en">Borisova AL, Pokrovskaya MS, Meshkov AN, et al. Risk mana­ge­ment in biobanking. Cardiovascular Therapy and Prevention. 2022;21(11):3400. (In Russ.) Борисова А. Л., Покровская М. С., Мешков А. Н. и др. Управление рисками в биобанкировании. Кардиоваскулярная терапия и профилактика. 2022;21(11): 3400. doi:10.15829/1728-8800-2022-3400.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Langhof H, Kahrass H, Sievers S, Strech D. Access policies in bio­bank research: what criteria do they include and how publicly available are they? A cross-­sectional study. Eur J Hum Genet. 2017;25(3):293-300. doi:10.1038/ejhg.2016.172.</mixed-citation><mixed-citation xml:lang="en">Langhof H, Kahrass H, Sievers S, Strech D. Access policies in bio­bank research: what criteria do they include and how publicly available are they? A cross-­sectional study. Eur J Hum Genet. 2017;25(3):293-300. doi:10.1038/ejhg.2016.172.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bledsoe MJ, Sexton KC. Ensuring Effective Utilization of Bio­spe­cimens: Design, Marketing, and Other Important Approaches. Bio­preserv Biobank. 2019;17(3):248-57. doi:10.1089/bio.2019.0007.</mixed-citation><mixed-citation xml:lang="en">Bledsoe MJ, Sexton KC. Ensuring Effective Utilization of Bio­spe­cimens: Design, Marketing, and Other Important Approaches. Bio­preserv Biobank. 2019;17(3):248-57. doi:10.1089/bio.2019.0007.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Henderson MK, Goldring K, Simeon-­Dubach D. Advancing Pro­fes­sionalization of Biobank Business Operations: Performance and Utilization. Biopreserv Biobank. 2019;17(3):213-8. doi:10. 1089/bio.2019.0005.</mixed-citation><mixed-citation xml:lang="en">Henderson MK, Goldring K, Simeon-­Dubach D. Advancing Pro­fes­sionalization of Biobank Business Operations: Performance and Utilization. Biopreserv Biobank. 2019;17(3):213-8. doi:10. 1089/bio.2019.0005.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Shaw DM, Elger BS, Colledge F. What is a biobank? Differing de­finitions among biobank stakeholders. Clin Genet. 2014;85(3): 223-7. doi:10.1111/cge.12268.</mixed-citation><mixed-citation xml:lang="en">Shaw DM, Elger BS, Colledge F. What is a biobank? Differing de­finitions among biobank stakeholders. Clin Genet. 2014;85(3): 223-7. doi:10.1111/cge.12268.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Rush A, Catchpoole DR, Ling R, et al. Improving Academic Biobank Value and Sustainability Through an Outputs Focus. Value Health. 2020;23(8):1072-8. doi:10.1016/j.jval.2020.05.010.</mixed-citation><mixed-citation xml:lang="en">Rush A, Catchpoole DR, Ling R, et al. Improving Academic Biobank Value and Sustainability Through an Outputs Focus. Value Health. 2020;23(8):1072-8. doi:10.1016/j.jval.2020.05.010.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">De Blasio P, Biunno I. New Challenges for Biobanks: Accreditation to the New ISO 20387:2018 Standard Specific for Biobanks. BioTech (Basel). 2021;10(3):13. doi:10.3390/biotech10030013.</mixed-citation><mixed-citation xml:lang="en">De Blasio P, Biunno I. New Challenges for Biobanks: Accreditation to the New ISO 20387:2018 Standard Specific for Biobanks. BioTech (Basel). 2021;10(3):13. doi:10.3390/biotech10030013.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Meinung B, Martin D, Zimmermann U. Standardization in bioban­king — between cooperation and competition. J Lab Med. 2019; 43(6):317-28. doi:10.1515/labmed-2019-0105.</mixed-citation><mixed-citation xml:lang="en">Meinung B, Martin D, Zimmermann U. Standardization in bioban­king — between cooperation and competition. J Lab Med. 2019; 43(6):317-28. doi:10.1515/labmed-2019-0105.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Engels C, Kern J, Dudová Z, et al. The sample locator: A federated search tool for biosamples and associated data in Europe using HL7 FHIR. Comput Biol Med. 2024;180:108941. doi:10.1016/j.compbiomed.2024.108941.</mixed-citation><mixed-citation xml:lang="en">Engels C, Kern J, Dudová Z, et al. The sample locator: A federated search tool for biosamples and associated data in Europe using HL7 FHIR. Comput Biol Med. 2024;180:108941. doi:10.1016/j.compbiomed.2024.108941.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;3:160018. doi:10.1038/sdata.2016.18.</mixed-citation><mixed-citation xml:lang="en">Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data. 2016;3:160018. doi:10.1038/sdata.2016.18.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Holub P, Kohlmayer F, Prasser F, et al. Enhancing Reuse of Data and Biological Material in Medical Research: From FAIR to FAIR-Health. Biopreserv Biobank. 2018;16(2):97-105. doi:10.1089/bio.2017.0110.</mixed-citation><mixed-citation xml:lang="en">Holub P, Kohlmayer F, Prasser F, et al. Enhancing Reuse of Data and Biological Material in Medical Research: From FAIR to FAIR-Health. Biopreserv Biobank. 2018;16(2):97-105. doi:10.1089/bio.2017.0110.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Rush A, Byrne JA, Watson PH. Applying Findable, Accessible, Intero­perable, and Reusable Principles to Biospecimens and Biobanks. Biopreserv Biobank. 2024;22(6):550-6. doi:10.1089/bio.2023.0110.</mixed-citation><mixed-citation xml:lang="en">Rush A, Byrne JA, Watson PH. Applying Findable, Accessible, Intero­perable, and Reusable Principles to Biospecimens and Biobanks. Biopreserv Biobank. 2024;22(6):550-6. doi:10.1089/bio.2023.0110.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Baláž V, Jeck T, Balog M. Economics of Biobanking: Business or Public Good? Literature Review, Structural and Thematic Analysis. Soc Sci. 2022;11(7):288. doi:10.3390/socsci11070288.</mixed-citation><mixed-citation xml:lang="en">Baláž V, Jeck T, Balog M. Economics of Biobanking: Business or Public Good? Literature Review, Structural and Thematic Analysis. Soc Sci. 2022;11(7):288. doi:10.3390/socsci11070288.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Мешков А. Н., Ярцева О. Ю., Борисова А. Л. и др. Концеп­ция национальной информационной платформы биобанков Российской Фе­де­ра­ции. Кардиовас­куляр­ная терапия и профилактика. 2022;21(11):3417. doi:10.15829/1728-8800-2022-3417.</mixed-citation><mixed-citation xml:lang="en">Meshkov AN, Yartseva OYu, Borisova AL, et al. The con­cept of the national information platform of biobanks of the Rus­sian Federa­tion. Cardiovascular Therapy and Preven­tion. 2022;21(11): 3417. (In Russ.) doi:10.15829/1728-8800-2022-3417.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">van der Stijl R, Manders P, Eijdems EWHM. Recommendations for a Dutch Sustainable Biobanking Environment. Biopreserv Biobank. 2021;19(3):228-40. doi:10.1089/bio.2021.0011.</mixed-citation><mixed-citation xml:lang="en">van der Stijl R, Manders P, Eijdems EWHM. Recommendations for a Dutch Sustainable Biobanking Environment. Biopreserv Biobank. 2021;19(3):228-40. doi:10.1089/bio.2021.0011.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
